Indianapolis, IN, United States of America

Guoqiang Zhou


 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Shanghai, CN (2016)
  • Indianapolis, IN (US) (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Guoqiang Zhou: Innovator in Pharmaceutical Compounds

Introduction

Guoqiang Zhou is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific medical conditions. With a total of 3 patents to his name, Zhou's work is recognized for its potential impact on liver disease treatment.

Latest Patents

Among his latest patents, Zhou has developed amino pyrimidine compounds that are useful as SSAO inhibitors. The present invention provides compounds of a specific formula, along with pharmaceutically acceptable salts of these compounds. Additionally, it outlines methods for treating patients suffering from liver disease and processes for preparing these innovative compounds.

Career Highlights

Guoqiang Zhou is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. Zhou's expertise and innovative approach have contributed to the advancement of medical treatments.

Collaborations

Zhou collaborates with talented colleagues, including Mengyang Fan and Luoheng Qin. These partnerships enhance the research environment and foster the development of new ideas and solutions in the pharmaceutical field.

Conclusion

Guoqiang Zhou's contributions to pharmaceutical innovations, particularly in the area of liver disease treatment, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…